These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36504054)

  • 1. [Value of thyroid
    Qi Y; Chi X; Jiang Y; Huang K; Liu F; Liu Z; Tang G; Li G
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 Nov; 42(11):1618-1627. PubMed ID: 36504054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possibility analysis of thyroid imaging parameters for dose adjustment in 131I treatment of hyperthyroidism.
    Zhang X; Li J; Zhou H; Lu Q; Wei H; Li A; Wei X; Wei Z
    Q J Nucl Med Mol Imaging; 2023 Jun; 67(2):152-157. PubMed ID: 34477345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioiodine therapy in patients with amiodarone-induced thyrotoxicosis (AIT).
    Czarnywojtek A; Czepczynski R; Ruchala M; Wasko R; Zgorzalewicz-Stachowiak M; Szczepanek E; Zamyslowska H; Bartkowiak Z; Florek E; Sowinski J
    Neuro Endocrinol Lett; 2009; 30(2):209-14. PubMed ID: 19675515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive factors for the outcomes of Graves' disease patients with radioactive iodine (131I) treatment.
    Xing YZ; Zhang K; Jin G
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31840740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasonographic thyroid volume as a reliable prognostic index of radioiodine-131 treatment outcome in Graves' disease hyperthyroidism.
    Gómez-Arnaiz N; Andía E; Gumà A; Abós R; Soler J; Gómez JM
    Horm Metab Res; 2003 Aug; 35(8):492-7. PubMed ID: 12953167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Presence of Anti-TPO Antibodies Increase the Likelihood of Post-I131 Hypothyroidism.
    Quataert F; Bravenboer B; Keyaerts M; Andreescu CE
    Horm Metab Res; 2024 Feb; 56(2):134-141. PubMed ID: 37931916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive factors for early hypothyroidism following the radioactive iodine therapy in Graves' disease patients.
    Hu RT; Liu DS; Li B
    BMC Endocr Disord; 2020 May; 20(1):76. PubMed ID: 32471411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration of radioactive iodine uptake after treatment of hyperthyroidism with iodine 131.
    Heath RC; Gossain VV; Rovner DR
    South Med J; 1988 May; 81(5):601-5. PubMed ID: 3368812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of radioiodine doses for 6-hr and 24-hour iodine-131 thyroid uptake values for Graves' hyperthyroidism.
    Horn-Lodewyk J
    Endocr J; 2019 Dec; 66(12):1047-1052. PubMed ID: 31391354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioactive iodine therapy in cats with hyperthyroidism.
    Turrel JM; Feldman EC; Hays M; Hornof WJ
    J Am Vet Med Assoc; 1984 Mar; 184(5):554-9. PubMed ID: 6706799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The predictive role of 24h RAIU with respect to the outcome of low fixed dose radioiodine therapy in patients with diffuse toxic goiter.
    Damle N; Bal C; Kumar P; Reddy R; Virkar D
    Hormones (Athens); 2012; 11(4):451-7. PubMed ID: 23422768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of clinical diagnosis model of Graves' disease and Hashimoto's thyroiditis.
    Cui Z; Wang Z; Liu X; Cai Y; Xu X; Yang T
    J Transl Med; 2019 Jan; 17(1):11. PubMed ID: 30616573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect tracking of
    Zhao Y; Tian X; Meng Z
    Hell J Nucl Med; 2023; 26(1):35-40. PubMed ID: 37031421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of radioactive iodine treatment of graves' hyperthyroidism using a single calculated
    Wong KK; Shulkin BL; Gross MD; Avram AM
    Clin Diabetes Endocrinol; 2018; 4():20. PubMed ID: 30505461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transition of nodular toxic goiter to autoimmune hyperthyroidism triggered by 131I therapy.
    Nygaard B; Faber J; Veje A; Hegedüs L; Hansen JM
    Thyroid; 1999 May; 9(5):477-81. PubMed ID: 10365679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid uptake of radioactive iodine in hyperthyroidism.
    Hooper PL; Caplan RH
    JAMA; 1977 Aug; 238(5):411-3. PubMed ID: 577556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of treatment of hyperthyroidism.
    Bringmann IM; van Leeuwen BL; Hennemann G; Beckett GJ; Toft AD
    J Endocrinol Invest; 1999 Apr; 22(4):250-6. PubMed ID: 10342357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The change in 123I-uptake between 3- and 24-hours is useful in predicting early response to methimazole in patients with Graves' disease.
    Gemma R; Nakamura H; Mori T; Andoh S; Suzuki Y; Yoshimi T
    Endocr J; 1996 Feb; 43(1):61-6. PubMed ID: 8732453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiometabolic treatment of hyperthyroidism with a calculated dose of 131-iodine: results of one-year follow-up.
    Regalbuto C; Marturano I; Condorelli A; Latina A; Pezzino V
    J Endocrinol Invest; 2009 Feb; 32(2):134-8. PubMed ID: 19411811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Success rate of radioactive iodine treatment for children and adolescent with hyperthyroidism.
    Namwongprom S; Dejkhamron P; Unachak K
    J Endocrinol Invest; 2021 Mar; 44(3):541-545. PubMed ID: 32583373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.